ILCA Systemic Therapies Guidance

Plenary Room "Roma"

Information

Systemic therapy continues to evolve rapidly and guidelines require updating accordingly. The online ILCA systemic therapy guidance provides up to date therapeutic algorithm supported by key data and links to relevant publications. During this session, the latest version of the guidelines will be presented. Delegates will:

• Receive topline data from recent practice changing trials

• Understand how the guidance has been amended in line with recent developments

• Have a forward look at trials on the horizon and emerging data from ongoing trials

Session Chair: Tim Meyer

International Liver Cancer AssociationILCA HUBThe International Liver Cancer Association (ILCA) is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines. ILCA’s mission is to lead a global community of physicians, scientists and allied professionals through education and research, with the goal to better prevent and treat liver cancer.

Speakers

Tim Meyer

ConsultantUCL Cancer Institute

Katie Kelley

Professor of Clinical Medicine Chair, Data and Safety Monitoring CommitteeHelen Diller Family Comprehensive Cancer Center University of California, San Francisco (UCSF)

Registered attendees

Marco Sanduzzi Zamparelli

MD, PhDBCLC group. Liver Unit. Hospital Clinic of Barcelona